Tower Research Capital LLC (Trc) Zai Lab LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Zai Lab LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 151 shares of ZLAB stock, worth $3,284. This represents 0.0% of its overall portfolio holdings.
Number of Shares
151
Previous 104,466
99.86%
Holding current value
$3,284
Previous $3.65 Million
99.86%
% of portfolio
0.0%
Previous 0.1%
Shares
28 transactions
Others Institutions Holding ZLAB
# of Institutions
154Shares Held
32.7MCall Options Held
168KPut Options Held
222K-
Capital World Investors Los Angeles, CA6.08MShares$132 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.52MShares$76.5 Million0.09% of portfolio
-
Rtw Investments, LP New York, NY2.29MShares$49.8 Million1.04% of portfolio
-
Janus Henderson Group PLC London, X02.05MShares$44.6 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA1.72MShares$37.4 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.13B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...